Goldman Sachs International (NSCIT1317253) News

Rizzo never turned into the anchor at first that the Yankees hoped for when he signed. I remember how he was supposed to crush HRs by the dozens into the short RF porch. Just didn't happen. And defensively, the disasterous 5th inning in the WS highlighted his limitations when it comes to moving. 'Lo

MNDY
Monday.com price target raised to $330 from $315 at Wells Fargo
Wells Fargo raised the firm's price target on Monday.com to $330 from $315 and keeps an Overweight rating on the shares. The firm notes feedback on Q3 plus Elevate conference was consistently strong, indicative of

Once again they put out news too early in the morning. Today it's an hour earlier 6:05. Very bad judgment on their part. Only thing that's up is the dog. It would make a bigger difference if it was out at 9 AM. Stupid people running the show if you ask me. Thinkorswim doesn't even show news is out.

ANF
Citi opens 'positive catalyst watch' on Abercrombie & Fitch into earnings
Citi opened a "30-day positive catalyst watch" on shares of Abercrombie & Fitch while keeping a Buy rating on the name with a $190 price target. The firm anticipates another "strong" Q3 earnings beat versu

If you signed up for email updates on PulsewireAI this is what you would have gotten recently:

Hi,



Thank you for signing up to stay updated!



We’re excited to announce that our groundbreaking platform will launch in December

$PTON upgraded to Buy from Underperform at BofA - raises PT to $9 from $3.75

Agreed.... and who wouldn't be? The guy is amazing!

( 4 ) Rallys today >

President Donald J. Trump, >

45th President of the United States of America,

will deliver remarks at a rally in

Raleigh, North Carolina on

Monday, November 4, 2024, at 10:00AM EST.

Wat

I found this paragraph in your link extremely interesting.

At its July 2024 Board meeting, MHRA Chief Executive Dr Raine described the future she envisions for regulatory authorisations saying , “it will not be a product that we authorise. Likely it’s a platform, ultimately and pati

True, but its always good to have options, as they maybe a sub-set of patients who respond better to one treatment or the other. That is the big unknown. But I am sure they have an idea and have been testing for biomarkers and DNA to determine who is responding best to each treatment.

Bawhahaha delusional clowns actually think they can give up their shares ! Yet not a one can explain how that would happen. Pretty much kills the whole stupid fantasy of bashers wanting their shares .
Idiots is putting it mildly.

SKYE: 30M OS - 80.70% Inst. Holdings - Financial Call on 11-07-24

https://investorshub.advfn.com/uimage/uploads/2024/11/4/ttcvnScreenshot_2024-11-04_at_06-23-40_SKYE_SharpCharts_StockCharts.com.png

Good morning!

“Failure is a bruise, not a tattoo.”

- Jon Sinclair

Good morning (RNVA-Land & Team).......🤑😎........Go (RNVA & Team)

🟩Lots of interest here in $HIRU🟩wow🟩🟩https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades

Well I'll be damned if both today and tomorrow aren't green.

🟩🟩wow $30 Possible🟩$GNCP🟩🟩https://gncc-capital.com/Highlights.html🟩

$COEP loading zone this week! Coeptis announced the expansion of its license agreement with Deverra Therapeutics, broadening the potential applications of its allogeneic natural killer #NKcell technology. #ICYMI, read the press release here: https://bit.ly/48mr5oR $COEP

" I know ~ I can tell he's very tired, from his last rally " .. !!

$ILLR Doing The $5 Dolla Holla This Week! 💥

https://investorshub.advfn.com/uimage/uploads/2024/11/4/zotoj5.png

This is the 10k, so I believe there's extra time allotted to file that vs the 10q.

$COEP News October 24, 2024

Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
https://finance.yahoo.com/news/coeptis-therapeutics-expands-license-agreement-120700632.html

$ILLR Doing The $5 Dolla Holla This Week! 💥

https://investorshub.advfn.com/uimage/uploads/2024/11/4/zotoj5.png

HCM results in December fast track FDA for
Orphan it's a winner chicken dinner back to the $2s

You are right I do not know much about the comparative safety profile. I have many peer-reviewed papers and documents from the MABs but almost nothing about the safety in AD from blarcamesine. Just 1 old summary slide and some statements. How to make a fair comparison then?
So you know this a